Biomedical Lab Supplies Producer Acumen Bags 100 Mn of CNY in Series A Round
In June 2022, Acumen Biomedical(Chinese:亚通生物) closed its Series A financing round worth nearly 100 million of CNY led by Apricot Capital(Chinese: 杏泽资本) with participation from Guolian Xinchuang(Chinese:无锡国联新创), BR Capital(Chinese:博润资本), Hoshi Capital(Chinese:红什资本). The proceeds will be used to further automate the company’s product lines and expand new product pipelines.
Founded in 2020, the startup is a producer of biomedical consumables, providing customers with comprehensive solutions and customized services for related consumables. Acumen entered the supplier system of some public-traded IVD companies thanks to its team’s experience and resources in product development, production management, etc.
Briefing Jun 24, 2022 11:15 AM
· Healthcare
F-star to be acquired by China biopharmaceutical with USD 161million
Briefing Jun 24, 2022 11:07 AM
· Healthcare
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
In-depth
Healthcare
2022 Informatization of China's Rehabilitation Industry
The rehabilitation industry caught the attention of the Chinese government again in 2021, and the industry entered a phase of accelerated development. The rehabilitation industry will first supplement medical resources and continue to explore a rehabilitation model that suits China's actual conditions. Under this context, EqualOcean Intelligence, together with Neusoft Group, released the 2022 Research Report On the Informatization of China's Rehabilitation Industry.
Sep 01, 2022 10:11 AM
Briefing Jun 24, 2022 10:46 AM
· Healthcare
East China medicine "liraglutide" goes to sea
Aug 29, 2022 05:45 PM
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Aug 09, 2020 12:23 AM
Briefing Jun 23, 2022 06:25 PM
· Healthcare
Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
Briefing Jun 23, 2022 06:24 PM
· Healthcare
Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing
Briefing Jun 23, 2022 10:36 AM
· Healthcare
Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China
Briefing Jun 23, 2022 10:27 AM
· Healthcare
Yanye new crown drug 3CL protein inhibitor has been suspended approval
Healthcare
Insight Lifetech Completes Series D+ Equity Round
Insight Lifetech, a high-tech company dedicated to providing innovative solutions for cardiovascular disease precision intervention, will continue to provide more innovative products and services and provide changes to precision diagnosis and treatment of cardiovascular diseases.
Updated 8 hours ago
Briefing Jun 23, 2022 10:24 AM
· Healthcare
Sanofi Greater China will be headed by Shi Wang, and Henting he will become the global head of the digital business unit
Briefing Jun 23, 2022 10:22 AM
· Healthcare
Acadia Alzheimer's drug SNDA application rejected by FDA advisory committee
Briefing Jun 23, 2022 10:20 AM
· Healthcare
Huashen Zhiyao completed nearly 500million yuan of a-round financing and went deep into AI new drug development
Briefing Jun 23, 2022 10:15 AM
· Healthcare
Huamei Haolian, a health management service enterprise, completed round a+ financing, and Jinshajiang venture capital led the investment
Briefing Jun 23, 2022 10:06 AM
· Healthcare
Mojia biology announced the completion of round B financing
Briefing Jun 23, 2022 09:50 AM
· Healthcare
First class recall of Draeger, a ventilator giant
Briefing Jun 22, 2022 02:30 PM
· Healthcare
The state plans to prohibit third-party platforms from directly participating in online drug sales
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth